Ibritumomab Tiuxetan and Perflutren lipid microsphere Intravenous
Determining the interaction of Ibritumomab Tiuxetan and Perflutren lipid microsphere Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Perflutren Lipid Microspheres
- Ibritumomab Tiuxetan-Perflutren Protein Type A
- Ibritumomab Tiuxetan-Perflutren protein type a microsphere Intravenous
- Ibritumomab Tiuxetan-Perforomist
- Ibritumomab Tiuxetan-Perforomist, Symbicort
- Ibritumomab Tiuxetan-Pergolide
- Perflutren lipid microsphere Intravenous-Ibrutinib
- Perflutren lipid microsphere Intravenous-Ibrutinib Capsules
- Perflutren lipid microsphere Intravenous-Ibrutinib Tablets
- Perflutren lipid microsphere Intravenous-Ibu
- Perflutren lipid microsphere Intravenous-IBU Tablets
- Perflutren lipid microsphere Intravenous-Ibu-2